These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


72 related items for PubMed ID: 3710420

  • 1. Hyperprolactinemia associated with chronic renal failure in the rat.
    Torres-Noriega J, Frohman LA.
    Horm Metab Res; 1986 Apr; 18(4):241-3. PubMed ID: 3710420
    [Abstract] [Full Text] [Related]

  • 2. [Possible mechanisms of the interaction between gonadotropins and prolactin in an experimental hyperprolactinemia model].
    Tresguerres JA, Esquifino AI.
    Acta Physiol Lat Am; 1983 Apr; 33(3):257-74. PubMed ID: 6424409
    [Abstract] [Full Text] [Related]

  • 3. Defective dopaminergic regulation of prolactin secretion in patients with hyperprolactinemia.
    Serri O, Beauregard H, Somma M, Comtois R, Jilwan N, Hardy J.
    Clin Invest Med; 1988 Dec; 11(6):387-91. PubMed ID: 3229037
    [Abstract] [Full Text] [Related]

  • 4. Suppressive effects of chronic hyperprolactinemia on penile erection and yawning following administration of apomorphine to pituitary-transplanted rats.
    Sato F, Aoki H, Nakamura K, Taguchi M, Aoki T, Yasuda N.
    J Androl; 1997 Dec; 18(1):21-5. PubMed ID: 9089064
    [Abstract] [Full Text] [Related]

  • 5. Dopaminergic inhibition of metoclopramide-induced aldosterone secretion in man. Dissociation of responses to dopamine and bromocriptine.
    Carey RM, Thorner MO, Ortt EM.
    J Clin Invest; 1980 Jul; 66(1):10-8. PubMed ID: 7400305
    [Abstract] [Full Text] [Related]

  • 6. Ethanol induces hyperprolactinemia by increasing prolactin release and lactotrope growth in female rats.
    De A, Boyadjieva N, Oomizu S, Sarkar DK.
    Alcohol Clin Exp Res; 2002 Sep; 26(9):1420-9. PubMed ID: 12351938
    [Abstract] [Full Text] [Related]

  • 7. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
    Pisarek H, Stepien H, Pawlikowski M.
    Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
    [Abstract] [Full Text] [Related]

  • 8. Evidence for lactotroph dopamine resistance in idiopathic hyperprolactinemia.
    Webb CB, Thominet JL, Barowsky H, Berelowitz M, Frohman LA.
    J Clin Endocrinol Metab; 1983 Jun; 56(6):1089-93. PubMed ID: 6841551
    [Abstract] [Full Text] [Related]

  • 9. Episodic prolactin release after removal of dopamine inhibition in vitro.
    Swearingen KC, Martínez de la Escalera G, Weiner RI.
    Bol Estud Med Biol; 1990 Jun; 38(3-4):43-8. PubMed ID: 2103743
    [Abstract] [Full Text] [Related]

  • 10. Effects of hyperprolactinemia on prolactin and LH pulsatile pattern in female rats.
    Lafuente A, Marcó J, Esquifino AI.
    Rev Esp Fisiol; 1992 Dec; 48(4):291-6. PubMed ID: 1302899
    [Abstract] [Full Text] [Related]

  • 11. Effects of cyclosporine on circulating levels of prolactin, LH, FSH, TSH and GH in chronic hyperprolactinemic male rats.
    Lafuente A, Alvarez-Demanuel E, Blanco A, García-Bonacho M, Esquifino AI.
    Rev Esp Fisiol; 1996 Sep; 52(3):161-6. PubMed ID: 8974151
    [Abstract] [Full Text] [Related]

  • 12. Opioids and the pulsatile prolactin secretory pattern: effects of hyperprolactinemia.
    Lafuente A, Marco J, Esquifino AI.
    Vet Hum Toxicol; 1994 Dec; 36(6):524-8. PubMed ID: 7900271
    [Abstract] [Full Text] [Related]

  • 13. Role of testicular interstitial macrophages in regulating testosterone release in hyperprolactinemia.
    Huang WJ, Yeh JY, Kan SF, Chang LS, Wang PS.
    J Cell Biochem; 2003 Mar 01; 88(4):766-73. PubMed ID: 12577310
    [Abstract] [Full Text] [Related]

  • 14. Catecholamines and pituitary function. VI. Effect of different dopamine doses on TRH-induced prolactin release in women with pathological hyperprolactinemia.
    Nicoletti I, Ambrosi F, Pagliacci MC, Pelicci G, Giammartino C, Maggio D, Fedeli L, Filipponi P.
    Horm Metab Res; 1987 Mar 01; 19(3):125-9. PubMed ID: 3106177
    [Abstract] [Full Text] [Related]

  • 15. A combination of Chinese herbs, Astragalus membranaceus var. mongholicus and Angelica sinensis, improved renal microvascular insufficiency in 5/6 nephrectomized rats.
    Song J, Meng L, Li S, Qu L, Li X.
    Vascul Pharmacol; 2009 Mar 01; 50(5-6):185-93. PubMed ID: 19563735
    [Abstract] [Full Text] [Related]

  • 16. Analysis of growth in five-sixths-nephrectomized rats.
    Santos F, Cobo A, Orejas G, Martínez V, Rey C, Málaga S, Crespo M.
    Miner Electrolyte Metab; 1996 Mar 01; 22(1-3):83-7. PubMed ID: 8676833
    [Abstract] [Full Text] [Related]

  • 17. In vivo and in vitro effects of cholecystokinin octapeptide on the release of prolactin in rats.
    Matsumura M, Yamanoi A, Yamamoto S, Mori H, Saito S.
    Horm Metab Res; 1985 Jun 01; 17(6):293-7. PubMed ID: 4018718
    [Abstract] [Full Text] [Related]

  • 18. Dopamine and bromocriptine inhibit cyclic AMP accumulation in the anterior pituitary: the effect of cholera toxin.
    Cronin MJ, Thorner MO.
    J Cyclic Nucleotide Res; 1982 Jun 01; 8(4):267-75. PubMed ID: 6300209
    [Abstract] [Full Text] [Related]

  • 19. Changes in the regulation of calcium metabolism and bone calcium content during growth in the absence of endogenous prolactin and during hyperprolactinemia: a longitudinal study in male and female Wistar rats.
    Piyabhan P, Krishnamra N, Limlomwongse L.
    Can J Physiol Pharmacol; 2000 Oct 01; 78(10):757-65. PubMed ID: 11077975
    [Abstract] [Full Text] [Related]

  • 20. The effects of dopamine, bromocriptine, lergotrile and metoclopramide on prolactin release from continuously perfused columns of isolated rat pituitary cells.
    Yeo T, Thorner MO, Jones A, Lowry PJ, Besser GM.
    Clin Endocrinol (Oxf); 1979 Feb 01; 10(2):123-30. PubMed ID: 34491
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 4.